IonGate Biosciences

IonGate Biosciences was a German biotechnology company specializing in the development of innovative screening technologies for drug discovery, specifically targeting membrane transporters and ion channels. The company's core technology, SURFE²R (Surface Electrogenic Event Reader), enabled the direct measurement of charge translocation across membranes, providing a high-throughput solution for studying electrogenic transporters. This platform allowed researchers to analyze transport proteins that were previously difficult to study using traditional patch-clamp methods. In 2011, the company's assets and technology were acquired by Nanion Technologies, which continues to develop and market the SURFE²R product line.